← SynDRA
LIMAPROST
SynDRA canonical compound SYN0032977 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | PTGER1 |
| Mechanism of action | prostanoid receptor agonist |
| Indication | claudication |
| Disease area | cardiology |
All known targets
Mechanisms of action (all sources)
- prostanoid receptor agonist
- PTGER1 AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- NR1I2
- HRH3
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MLNR
- NPY1R
- NR3C1
- ADORA2A
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PPARG
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- HRH2
- HRH1
- HDAC6
- GHSR
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- AVPR2
Drug classes
- Cardiovascular Agents
- Vasodilator Agents
ATC classes
- B01A · ANTITHROMBOTIC AGENTS
Cross-references
Synonyms
- opalmon
- limaprost alfadex
- ONO1206
- ONO 1206
- Limaprost alfadex
- Opalmon (TN)
- Limaprostum
- L02U804092
- RefChem:153454
- DTXCID401476393
- Limaprost alpha-cyclodextrin clathrate
- ONO-1206
- Limaprost [INN]
- OP 1206
- Limaprost (INN)
- Limaprostum [Latin]
- limaprost-alfadex
- LIMAPROST [JAN]
- LIMAPROST [MI]
- Ono-1206.alpha-CD
- Limaprost alfadex [JAN]
- OP-1206.alpha-CD
- Prostaglandin Impurity 48
- LIMAPROST [MART.]
- Limaprost alpha-cyclodextrin
- LIMAPROST [WHO-DD]
- SCHEMBL373011
- orb1707065
- Limaprost, >=99%, crystalline
- CHEBI:135594
- OJZYRQPMEIEQFC-UAWLTFRCSA-N
- GLXC-08154
- HMS3648D21
- UNII-L02U804092
- LIMAPROST ALFADEX [WHO-DD]
- EX-A4260
- HY-B0683
- MFCD00868275
Look up LIMAPROST in the interactive SynDRA portal →